Previous reports showed that microRNA-122 inhibited HCC cell progression via targeting LMNB2 [26] and confered sorafenib resistance to HCC cells by RAS/RAF/ERK signaling pathway [30]. The gene discussed is LMNB2; the disease is hepatocellular carcinoma.